Would you offer chemotherapy to a postmenopausal woman with microinvasive ER/PR positive, Her2 negative invasive ductal carcinoma with a single lymph node metastasis and insufficient tissue for Oncotype testing?

Topics: Breast Cancer • Medical Oncology • HR+

Answer from: Medical Oncologist at Academic Institution

I would want to obtain information about how strongly ER and/or PR positive the cancer was on IHC, and also the size of the lymph node metastasis. The other information that would play a role for me here would be the patient's age, Ki67 (if available), tumor grade, and any other comorbidities. Since...

Comments

Medical Oncologist at Southcoast Centers for Cancer Care
The patient is 63 with no co-morbidities. A biopsy...

Answer from: Medical Oncologist at Academic Institution

Agree with the above. Other ways to predict the benefit/impact of chemotherapy include tools such as Predict UK and also Magee equations to help gather information to counsel the patient.

Related Questions